Literature DB >> 21518860

ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors.

Paul L Bollyky1, Rebecca P Wu, Ben A Falk, James D Lord, S Alice Long, Anton Preisinger, Brandon Teng, Gregory E Holt, Nathan E Standifer, Kathleen R Braun, Cindy Fang Xie, Peter L Samuels, Robert B Vernon, John A Gebe, Thomas N Wight, Gerald T Nepom.   

Abstract

We describe a role for ECM as a biosensor for inflammatory microenvironments that plays a critical role in peripheral immune tolerance. We show that hyaluronan (HA) promotes induction of Foxp3- IL-10-producing regulatory T cells (TR1) from conventional T-cell precursors in both murine and human systems. This is, to our knowledge, the first description of an ECM component inducing regulatory T cells. Intact HA, characteristic of healing tissues, promotes induction of TR1 capable of abrogating disease in an IL-10-dependent mouse colitis model whereas fragmentary HA, typical of inflamed tissues, does not, indicating a decisive role for tissue integrity in this system. The TR1 precursor cells in this system are CD4(+)CD62L(-)FoxP3(-), suggesting that effector memory cells assume a regulatory phenotype when they encounter their cognate antigen in the context of intact HA. Matrix integrity cues might thereby play a central role in maintaining peripheral tolerance. This TR1 induction is mediated by CD44 cross-linking and signaling through p38 and ERK1/2. This induction is suppressed, also in a CD44-dependent manner, by osteopontin, a component of chronically inflamed ECM, indicating that CD44 signaling serves as a nexus for fate decisions regarding TR1 induction. Finally, we demonstrate that TR1 induction signals can be recapitulated using synthetic matrices. These results reveal important roles for the matrix microenvironment in immune regulation and suggest unique strategies for immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518860      PMCID: PMC3093524          DOI: 10.1073/pnas.1017360108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

2.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

3.  Propagation and control of T cell responses by heparan sulfate-bound IL-2.

Authors:  Lucile E Wrenshall; Jeffrey L Platt; Elliot T Stevens; Thomas N Wight; John D Miller
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

4.  IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.

Authors:  Pedro L Vieira; Jillian R Christensen; Sophie Minaee; Emma J O'Neill; Franck J Barrat; André Boonstra; Thomas Barthlott; Brigitta Stockinger; David C Wraith; Anne O'Garra
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 5.  A crucial role for CD44 in inflammation.

Authors:  E Puré; C A Cuff
Journal:  Trends Mol Med       Date:  2001-05       Impact factor: 11.951

Review 6.  Regulation of T-helper-cell lineage development by osteopontin: the inside story.

Authors:  Harvey Cantor; Mari L Shinohara
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

7.  Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype.

Authors:  Claudia Kemper; Andrew C Chan; Jonathan M Green; Kelly A Brett; Kenneth M Murphy; John P Atkinson
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

8.  Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3).

Authors:  Anders Elm Pedersen; Monika Gad; Mark R Walter; Mogens Helweg Claesson
Journal:  Immunol Lett       Date:  2004-01-30       Impact factor: 3.685

9.  Crosslinking of CD44 on human osteoblastic cells upregulates ICAM-1 and VCAM-1.

Authors:  Yuko Fujii; Koichi Fujii; Kazuhisa Nakano; Yoshiya Tanaka
Journal:  FEBS Lett       Date:  2003-03-27       Impact factor: 4.124

Review 10.  Extracellular matrix and cytokines: a functional unit.

Authors:  E Schönherr; H J Hausser
Journal:  Dev Immunol       Date:  2000
View more
  67 in total

Review 1.  The extracellular matrix: an active or passive player in fibrosis?

Authors:  Thomas N Wight; Susan Potter-Perigo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-21       Impact factor: 4.052

2.  Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios.

Authors:  Jörn-Hendrik Weitkamp; Tatsuki Koyama; Michael T Rock; Hernan Correa; Jeremy A Goettel; Pranathi Matta; Kyra Oswald-Richter; Michael J Rosen; Brian G Engelhardt; Daniel J Moore; D Brent Polk
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

Review 3.  The translational imperative: making cell therapy simple and effective.

Authors:  Glenn D Prestwich; Isaac E Erickson; Thomas I Zarembinski; Michael West; William P Tew
Journal:  Acta Biomater       Date:  2012-07-07       Impact factor: 8.947

4.  Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model.

Authors:  Jonathan M Fishman; Mark W Lowdell; Luca Urbani; Tahera Ansari; Alan J Burns; Mark Turmaine; Janet North; Paul Sibbons; Alexander M Seifalian; Kathryn J Wood; Martin A Birchall; Paolo De Coppi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

Review 5.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

6.  TSG-6 is highly expressed in human abdominal aortic aneurysms.

Authors:  S Keisin Wang; Jie Xie; Linden A Green; Robert A McCready; Raghu L Motaganahalli; Andres Fajardo; Clifford C Babbey; Michael P Murphy
Journal:  J Surg Res       Date:  2017-08-12       Impact factor: 2.192

Review 7.  Extracellular Matrix-Based Strategies for Immunomodulatory Biomaterials Engineering.

Authors:  Andrew T Rowley; Raji R Nagalla; Szu-Wen Wang; Wendy F Liu
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

8.  Alterations in osteopontin modify muscle size in females in both humans and mice.

Authors:  Eric P Hoffman; Heather Gordish-Dressman; Virginia D McLane; Joseph M Devaney; Paul D Thompson; Paul Visich; Paul M Gordon; Linda S Pescatello; Robert F Zoeller; Niall M Moyna; Theodore J Angelopoulos; Elena Pegoraro; Gregory A Cox; Priscilla M Clarkson
Journal:  Med Sci Sports Exerc       Date:  2013-06       Impact factor: 5.411

Review 9.  The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation.

Authors:  Paul L Bollyky; Marika Bogdani; Jennifer B Bollyky; Rebecca L Hull; Thomas N Wight
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

10.  Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.

Authors:  Nadine Nagy; Vivekananda G Sunkari; Gernot Kaber; Sonia Hasbun; Dung N Lam; Cate Speake; Srinath Sanda; Tracey L McLaughlin; Thomas N Wight; Steven R Long; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-09-06       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.